METHOD OF TREATING CATARACT IN PATIENTS WITH PSEUDOEXFOLIATION SYNDROME Russian patent published in 2014 - IPC A61F9/00 A61M5/46 A61K38/50 A61P27/12 

FIELD: medicine.

SUBSTANCE: prior to and after a cataract extraction with an IOL implantation, a lymphotropic therapy is conducted by pterygopalatine injections from the side of an involved eye within the course of 4 procedures. A therapeutic mixture containing lidocaine 50-100 mg, histochrom 0.2-0.4 mg, dalargin 0.5-1.0 mg, lidase 16-32 Units is used for injections. The first procedure of injections is conducted one or two days prior to the operation, and another three procedures - after the operation, daily. The pterygopalatine injections are combined with an intravenous administration of ozonised 0.9% sodium chloride in the ozone concentration of 2-4 mg/l.

EFFECT: fast income and accumulation of the therapeutic substances in the lymphatic orbit, reduced length of treatment and eliminated side complications in the combined pathogenic effect of the drug preparations.

2 cl, 2 ex